Literature DB >> 10917780

Nosocomial fungaemia: a 2-year prospective study.

S F Costa1, I Marinho, E A Araújo, A E Manrique, E A Medeiros, A S Levin.   

Abstract

Eighty-six consecutive patients with fungaemia were studied during a period of 2 years, 81% had two or more positive blood cultures. Gastrointestinal tract (28%) and haematological diseases (17%) were the most common underlying conditions. The majority of cases had received vancomycin and/or imipenem (87%) and a central venous catheter (78%). Candida albicans (50%) and Candida parapsilosis (17%) were the most frequent isolates. Overall mortality was 41%, and for patients with Candida tropicalis was 71%. There was not significant difference in survival with gender, age and days of treatment with antifungal drugs. Haematological diseases, neutropenia and a higher number of positive blood cultures were associated with poor outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917780     DOI: 10.1053/jhin.1999.0670

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  12 in total

1.  Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.

Authors:  Arnaldo L Colombo; Marcio Nucci; Benjamin J Park; Simone A Nouér; Beth Arthington-Skaggs; Daniel A da Matta; David Warnock; Juliette Morgan
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 2.  Candida Biofilms: Development, Architecture, and Resistance.

Authors:  Jyotsna Chandra; Pranab K Mukherjee
Journal:  Microbiol Spectr       Date:  2015-08

3.  Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.

Authors:  R Cisterna; G Ezpeleta; O Telleria; J Guinea; B Regueiro; J Garcia-Rodríguez; J Esperalba
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

Review 4.  Invasive candidiasis in pediatric intensive care units.

Authors:  Sunit Singhi; Akash Deep
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

5.  Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil.

Authors:  Marcello Mihailenko Chaves Magri; Michele Soares Gomes-Gouvêa; Vera Lúcia Teixeira de Freitas; Adriana Lopes Motta; Maria Luiza Moretti; Maria Aparecida Shikanai-Yasuda
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

6.  Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil.

Authors:  Marcos Paulo Wille; Thaís Guimarães; Guilherme Henrique Campos Furtado; Arnaldo Lopes Colombo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

7.  Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit.

Authors:  Ali Ertug Arslankoylu; Necdet Kuyucu; Berna Seker Yilmaz; Semra Erdogan
Journal:  Ital J Pediatr       Date:  2011-11-21       Impact factor: 2.638

8.  A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance.

Authors:  Rakhshanda Erum; Farkhunda Samad; Adnan Khan; Shahana Urooj Kazmi
Journal:  BMC Microbiol       Date:  2020-12-03       Impact factor: 3.605

9.  Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.

Authors:  Chun-fang Ma; Fang-qiu Li; Li-ning Shi; Yu-an Hu; Ying Wang; Mei Huang; Qian-qian Kong
Journal:  BMC Infect Dis       Date:  2013-07-22       Impact factor: 3.090

Review 10.  Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.

Authors:  Daniel Archimedes da Matta; Ana Carolina Remondi Souza; Arnaldo Lopes Colombo
Journal:  J Fungi (Basel)       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.